Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research

Nanomaterials for Cancer Diagnostics and Therapeutics
Northwestern University

Center Overview

Under the co-leadership of Drs. Chad Mirkin, driving the nanotechnology effort, and Steven Rosen, driving the clinical translational oncology effort, the NU-CCNE represents a strongly integrated partnership between the International Institute for Nanotechnology and the Robert H. Lurie Comprehensive Cancer Center. The primary goal of this new NU-CCNE program is to advance nanotechnology discoveries (e.g., materials, tools, and devices) for brain, breast, and pancreatic cancer diagnostics, imaging, and therapeutics that have strong potential for clinical utility and for use in many other forms of cancer research and treatment.

Center Investigators

Chad A. Mirkin, Ph.D.
Principal Investigator


Steven T. Rosen, M.D.
Principal Investigator

For more information about the Northwestern University Center of Cancer Nanotechnology Excellence visit our website at:

View all Alliance News